Related Experiment Video
Updated: Mar 22, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[Chronic diarrhoea due to microscopic colitis: awareness pays]
Bas P M Verhaegh1, Maarten A van Dijk, Danny Goudkade
1Maastricht Universitair Medisch Centrum+, Maastricht.
Increased awareness of microscopic colitis (MC) can lead to faster diagnosis and effective treatment with budesonide. Recognizing potential drug triggers, like NSAIDs, also aids in resolving chronic diarrhoea.
Area of Science:
- Gastroenterology
- Pathology
Background:
- Microscopic colitis (MC) incidence is rising in The Netherlands, though case numbers remain lower than in other nations.
- Physician and pathologist awareness may significantly impact MC diagnosis rates.
Observation:
- Two distinct cases of chronic diarrhoea are presented, highlighting diagnostic challenges.
- One patient was diagnosed with MC after a biopsy revision, responding well to budesonide.
- Another patient's MC resolved upon withdrawal of NSAID medication, suggesting a drug-related etiology.
Findings:
- MC awareness can expedite the diagnosis of chronic diarrhoea.
- Early diagnosis facilitates the use of budesonide, a highly effective MC treatment.
- Identifying and withdrawing causative drugs, such as NSAIDs, is a viable treatment strategy.
Implications:
- Enhanced clinical awareness of MC is crucial for timely diagnosis and management.
- Budesonide offers a potent therapeutic option for patients with microscopic colitis.
- Understanding drug-associated risks for MC can guide treatment decisions and improve patient outcomes.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Fungal Phylum Microsporidia
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

